在中低收入国家,由于筛查和护理机会有限,获得乳腺癌或宫颈癌早期诊断的妇女不足20%,而在高收入国家,这一比例超过30%。 Less than 20% of women in low- and middle-income countries get early diagnosis for breast or cervical cancer, compared to over 30% in high-income nations, due to limited screening and care access.

一项全球研究发现,在中低收入国家,由于筛查、医疗保健和治疗基础设施有限,早期被诊断患有乳腺癌或宫颈癌的妇女不到20%,而在高收入国家,这一比例超过30%。 A global study finds that less than 20% of women in low- and middle-income countries (LMICs) are diagnosed with breast or cervical cancer at an early stage, compared to over 30% in high-income nations, due to limited screening, healthcare access, and treatment infrastructure. 代谢性乳腺癌在LMICs中更为常见,治疗机会滞后,只有56%的人接受外科手术,而较富裕国家的这一比例为78%。 Metastatic breast cancer is far more common in LMICs, and treatment access lags, with only 56% receiving surgery versus 78% in wealthier countries. 全世界早期诊断和护理坚持率仍然很低,特别是卵巢癌的早期诊断和护理坚持率仍然很低,这突出表明迫切需要改善卫生系统、提供资金和公平获得预防和治疗服务。 Early diagnosis and care adherence remain low worldwide, especially for ovarian cancer, highlighting urgent needs for improved health systems, funding, and equitable access to prevention and treatment.